Si Hyoung Kim
About
In The Last Decade
Si Hyoung Kim
19 papers receiving 407 citations
Hit Papers
Peers
Comparison fields: 5 of 67
- Molecular Biology 225
- Endocrinology, Diabetes and Metabolism 101
- Oncology 69
- Cardiology and Cardiovascular Medicine 51
- Organic Chemistry 46
Countries citing papers authored by Si Hyoung Kim
This map shows the geographic impact of Si Hyoung Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Si Hyoung Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Si Hyoung Kim more than expected).
Fields of papers citing papers by Si Hyoung Kim
This network shows the impact of papers produced by Si Hyoung Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Si Hyoung Kim. The network helps show where Si Hyoung Kim may publish in the future.
Co-authorship network of co-authors of Si Hyoung Kim
This figure shows the co-authorship network connecting the top 25 collaborators of Si Hyoung Kim. A scholar is included among the top collaborators of Si Hyoung Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Si Hyoung Kim. Si Hyoung Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Association of the atherogenic index of plasma with cardiovascular risk beyond the traditional risk factors: a nationwide population-based cohort study breakdown → | 97 |
| 2 | 3 | |
| 3 | 12 | |
| 4 | 20 | |
| 5 | 9 | |
| 6 | 14 | |
| 7 | 7 | |
| 8 | 5 | |
| 9 | 39 | |
| 10 | 32 | |
| 11 | 17-Allylamino-17-demethoxygeldanamycin and Herbimycin A Induce Cell Death by Modulating β-Catenin and PI3K/AKT Signaling in FRO Anaplastic Thyroid Carcinoma Cells. | 9 |
| 12 | Suppression of AKT Potentiates Synergistic Cytotoxicity of Apigenin with TRAIL in Anaplastic Thyroid Carcinoma Cells. | 22 |
| 13 | 6 | |
| 14 | 16 | |
| 15 | 31 | |
| 16 | 30 | |
| 17 | Tunicamycin induces paraptosis potentiated by inhibition of BRAFV600E in FRO anaplastic thyroid carcinoma cells. | 12 |
| 18 | Hsp70 inhibition potentiates radicicol-induced cell death in anaplastic thyroid carcinoma cells. | 17 |
| 19 | 31 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.